483 Par Pharmaceuticals Sep 2019

483 Par Pharmaceuticals Sep 2019

Linda Murphy FDA$119.00 - Available Now

FDA investigators audited the Par Pharmaceuticals - Irvine, CA, United States facility and issued inspectional observations (via FDA 483) on 06 Sep 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Sep 2019
  • Location: Irvine, United States
  • FEI: 3004492248
Add To Cart